Enlightenment Research’s Opko Health OPK Stock Holding History

Enlightenment Research’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,200	Closed	-$4K	–	483
2018 Q4	$4K	Buy	+1,200	New	+$4.07K	0.01%	719

Other funds holding OPK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Enlightenment Research's OPK Position: Q1 2019 in Review

Enlightenment Research sold out of Opko Health (OPK) in Q1 2019, closing a stake of 1,200 shares — an estimated $4K sold.

Enlightenment Research first reported a position in OPK in Q4 2018 and held it in 1 quarter. The position peaked at $4K in Q4 2018. 201 funds tracked by Wall St. Rank hold OPK as of Q1 2019.

Enlightenment Research reported no remaining Opko Health position as of Q1 2019 after selling out during the quarter.
Enlightenment Research sold 1,200 Opko Health shares in Q1 2019, an estimated $4K.
Enlightenment Research first reported a position in Opko Health in Q4 2018 and held it in 1 quarter.
Enlightenment Research's Opko Health position peaked at $4K in Q4 2018.
201 funds tracked by Wall St. Rank held Opko Health as of Q1 2019.

Based on Enlightenment Research's 13F filing for Q1 2019, filed 3 May 2019.